Experimental treatment restores sight to man with genetic eye disorder in Italy
By Euronews Published on 30/07/2025 – 13:02 GMT+2 ADVERTISEMENT In a world first, a man suffering from vision loss…
FDA clears way for Sarepta Therapeutics to use Duchenne drug in some patients
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to market
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Sarepta will stop shipping Elevidys, Duchenne gene therapy
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Sarepta Therapeutics’ Duchenne therapy crisis has a clear lesson
In a matter of a few days last week, Sarepta Therapeutics announced major layoffs, acknowledged the death of…
Sarepta Therapeutics crisis is huge blow to Duchenne families, company
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…